chlorine has been researched along with Infarction, Middle Cerebral Artery in 9 studies
chloride : A halide anion formed when chlorine picks up an electron to form an an anion.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ferric chloride-induced distal middle cerebral artery occlusion (MCAO) model of stroke was described in mice several years ago, however it lacked in-depth evaluation of the post-stroke functional outcomes in the animals." | 7.96 | Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke. ( Alamri, FF; Arumugam, TV; Jayaraman, S; Karamyan, ST; Karamyan, VT; Lee, P; Syeara, N, 2020) |
| "Ferric chloride-induced distal middle cerebral artery occlusion (MCAO) model of stroke was described in mice several years ago, however it lacked in-depth evaluation of the post-stroke functional outcomes in the animals." | 3.96 | Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke. ( Alamri, FF; Arumugam, TV; Jayaraman, S; Karamyan, ST; Karamyan, VT; Lee, P; Syeara, N, 2020) |
| "In this study, cerebral ischemia was modeled using the middle cerebral artery occlusion method." | 1.72 | Upregulation of MiRNA-149-5p Reduces the Infract Volume in Middle Cerebral Artery Occlusion Rats by Modulating Cation-Chloride Cotransporters Expressions ( Amoli, N; Eskandari, M; Forouzandeh, M; Ghasemloo, E; Hosseini, M; Mostafavi, H, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, YH | 1 |
| Zhao, JH | 1 |
| Zong, WF | 1 |
| Wei, XJ | 1 |
| Xu, Z | 1 |
| Yuan, Y | 1 |
| Jiang, YF | 1 |
| Luo, X | 1 |
| Wang, W | 1 |
| Qu, WS | 1 |
| Mostafavi, H | 1 |
| Amoli, N | 1 |
| Ghasemloo, E | 1 |
| Forouzandeh, M | 1 |
| Hosseini, M | 1 |
| Eskandari, M | 1 |
| Zhang, H | 1 |
| Wang, X | 1 |
| Chen, W | 1 |
| Yang, Y | 1 |
| Wang, Y | 1 |
| Wan, H | 1 |
| Zhu, Z | 1 |
| Syeara, N | 1 |
| Alamri, FF | 1 |
| Jayaraman, S | 1 |
| Lee, P | 1 |
| Karamyan, ST | 1 |
| Arumugam, TV | 1 |
| Karamyan, VT | 1 |
| Martinez de Lizarrondo, S | 1 |
| Gakuba, C | 1 |
| Herbig, BA | 1 |
| Repessé, Y | 1 |
| Ali, C | 1 |
| Denis, CV | 1 |
| Lenting, PJ | 1 |
| Touzé, E | 1 |
| Diamond, SL | 1 |
| Vivien, D | 1 |
| Gauberti, M | 1 |
| Stocker, TJ | 1 |
| Pircher, J | 1 |
| Skenderi, A | 1 |
| Ehrlich, A | 1 |
| Eberle, C | 1 |
| Megens, RTA | 1 |
| Petzold, T | 1 |
| Zhang, Z | 1 |
| Walzog, B | 1 |
| Müller-Taubenberger, A | 1 |
| Weber, C | 1 |
| Massberg, S | 1 |
| Ishikawa-Ankerhold, H | 1 |
| Schulz, C | 1 |
| Hao, XZ | 1 |
| Yin, LK | 1 |
| Zhang, XX | 1 |
| Tian, JQ | 1 |
| Li, CC | 1 |
| Feng, XY | 1 |
| Jiang, M | 1 |
| Yang, YM | 1 |
| Dhanesha, N | 1 |
| Prakash, P | 1 |
| Doddapattar, P | 1 |
| Khanna, I | 1 |
| Pollpeter, MJ | 1 |
| Nayak, MK | 1 |
| Staber, JM | 1 |
| Chauhan, AK | 1 |
| Karatas, H | 1 |
| Erdener, SE | 1 |
| Gursoy-Ozdemir, Y | 1 |
| Gurer, G | 1 |
| Soylemezoglu, F | 1 |
| Dunn, AK | 1 |
| Dalkara, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TOLERANCE STUDY OF N-ACETYLCYSTEINE FOR THROMBOLYSIS IN THE ACUTE PHASE OF ISCHEMIC STROKE / ETUDE DE TOLERANCE DE LA N-ACETYLCYSTEINE POUR LA THROMBOLYSE A LA PHASE AIGUË DE L'INFARCTUS CEREBRAL[NCT04920448] | Phase 2 | 19 participants (Anticipated) | Interventional | 2021-06-07 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for chlorine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Acute Treatment with Nicotinamide Riboside Chloride Reduces Hippocampal Damage and Preserves the Cognitive Function of Mice with Ischemic Injury.
Topics: Animals; Chlorides; Cognition; Hippocampus; Infarction, Middle Cerebral Artery; Mice; NAD; Niacinami | 2022 |
Upregulation of MiRNA-149-5p Reduces the Infract Volume in Middle Cerebral Artery Occlusion Rats by Modulating Cation-Chloride Cotransporters Expressions
Topics: Animals; Brain Ischemia; Cations; Chlorides; Infarction, Middle Cerebral Artery; MicroRNAs; Rats; Sy | 2022 |
Danhong injection alleviates cerebral ischemia-reperfusion injury by inhibiting autophagy through miRNA-132-3p/ATG12 signal axis.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Autophagy-Related Protein 12; Autophag | 2023 |
Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke.
Topics: Animals; Behavior, Animal; Cerebral Cortex; Cerebral Infarction; Chlorides; Disease Models, Animal; | 2020 |
Potent Thrombolytic Effect of
Topics: Acetylcysteine; Animals; Blood Platelets; Chlorides; Disease Models, Animal; Ferric Compounds; Fibri | 2017 |
The Actin Regulator Coronin-1A Modulates Platelet Shape Change and Consolidates Arterial Thrombosis.
Topics: Actin Cytoskeleton; Animals; Blood Platelets; Cell Shape; Cells, Cultured; Chlorides; Cofilin 1; Col | 2018 |
Combining systemic and stereotactic MEMRI to detect the correlation between gliosis and neuronal connective pathway at the chronic stage after stroke.
Topics: Analysis of Variance; Animals; CD11b Antigen; Chlorides; Disease Models, Animal; Glial Fibrillary Ac | 2016 |
Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Topics: ADAMTS13 Protein; Animals; Blood Platelets; Bone Marrow Transplantation; Carotid Artery Diseases; Ch | 2016 |
Thrombotic distal middle cerebral artery occlusion produced by topical FeCl(3) application: a novel model suitable for intravital microscopy and thrombolysis studies.
Topics: Administration, Topical; Animals; Chlorides; Ferric Compounds; Infarction, Middle Cerebral Artery; M | 2011 |